Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas van Es

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Behavioral and Brain Sciences|September 29, 2022
Free-energy pragmatics: Markov blankets don't prescribe objective ontology, and that's okayInês Hipólito, Thomas van Es
Frontiers in Psychology|May 16, 2022
Enactive-Dynamic Social Cognition and Active InferenceInês Hipólito, Thomas van Es
Current Pharmaceutical Design|May 29, 2012
Cellular players in lung fibrosisAnnemarie N Lekkerkerker, Jamil Aarbiou, Thomas van Es, et al.
Future Cardiology|October 7, 2009
A vaccine against atherosclerosis: myth or reality?Gijs Hm van Puijvelde, Thomas van Es, Kim Ll Habets, et al.
Current Opinion in Lipidology|September 22, 2007
Immunomodulation of the inflammatory response in atherosclerosisJohan Kuiper, Gijs H M van Puijvelde, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2013
Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycansDinja Oosterhoff, Moniek Heusinkveld, Sinéad M Lougheed, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 2007
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient miceEva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 20, 2011
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccineRolf J Verheul, Niels Hagenaars, Thomas van Es, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Behavioral and Brain Sciences|September 29, 2022
Free-energy pragmatics: Markov blankets don't prescribe objective ontology, and that's okayInês Hipólito, Thomas van Es
Frontiers in Psychology|May 16, 2022
Enactive-Dynamic Social Cognition and Active InferenceInês Hipólito, Thomas van Es
Current Pharmaceutical Design|May 29, 2012
Cellular players in lung fibrosisAnnemarie N Lekkerkerker, Jamil Aarbiou, Thomas van Es, et al.
Future Cardiology|October 7, 2009
A vaccine against atherosclerosis: myth or reality?Gijs Hm van Puijvelde, Thomas van Es, Kim Ll Habets, et al.
Current Opinion in Lipidology|September 22, 2007
Immunomodulation of the inflammatory response in atherosclerosisJohan Kuiper, Gijs H M van Puijvelde, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2013
Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycansDinja Oosterhoff, Moniek Heusinkveld, Sinéad M Lougheed, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 2007
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient miceEva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 20, 2011
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccineRolf J Verheul, Niels Hagenaars, Thomas van Es, et al.
Pageof 1